{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-25-000036","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.103525+00:00","generated_at":"2026-05-23T01:26:14.317905+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cardinal Health Q3 non-GAAP EPS $2.35, up 13% YoY; raises FY25 EPS guidance to $8.05-$8.15","bullets":["Revenue $54.9B flat YoY; up 19% ex-customer contract expiration.","GAAP diluted EPS $2.10; non-GAAP $2.35, up 13% on 21% non-GAAP op earnings growth.","Pharma & Specialty segment profit $662M (+14%); Medical segment profit $39M (+77%).","FY25 non-GAAP EPS guidance raised to $8.05-$8.15 from $7.85-$8.00.","Completed acquisition of Advanced Diabetes Supply Group on Apr 1; $375M ASR program executed."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-25-000036","json":"https://secwatch.observer/filing/0000721371-25-000036.json","markdown":"https://secwatch.observer/filing/0000721371-25-000036.md","text":"https://secwatch.observer/filing/0000721371-25-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137125000036/0000721371-25-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137125000036/cah-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T01:26:14.317905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}